<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" orientation="portrait" position="float">
 <label>Table 1.
  <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml"> </span>
 </label>
 <caption>
  <title>Comparison between severe acute respiratory syndrome coronavirus 2, severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus.</title>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
  </colgroup>
  <thead valign="top">
   <tr>
    <th align="left">Virus</th>
    <th align="left">SARS-CoV-2</th>
    <th align="left">SARS-CoV</th>
    <th align="left">MERS-CoV</th>
    <th align="left">Ref.</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left">Outbreak year</td>
    <td align="left">2019</td>
    <td align="left">2003</td>
    <td align="left">2012</td>
    <td align="left"> </td>
   </tr>
   <tr>
    <td align="left">Outbreak countries</td>
    <td align="left">More than 184 countries, including USA, China, Japan, Korea, Italy, etc.</td>
    <td align="left">29 countries, including China, Vietnam, Singapore and Canada</td>
    <td align="left">&gt;27 countries, mainly in Saudi Arabia, South Korea, Jordan and Qatar</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B81">81</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Natural reservoir</td>
    <td align="left">Not identified</td>
    <td align="left">Bat</td>
    <td align="left">Bat</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B81">81</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Receptor</td>
    <td align="left">ACE2</td>
    <td align="left">ACE2, CD206</td>
    <td align="left">Dpp4 (CD26)</td>
    <td align="left"> </td>
   </tr>
   <tr>
    <td align="left">Fatality rate%</td>
    <td align="left">Not identified, at least 2–3%</td>
    <td align="left">10%</td>
    <td align="left">37%</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B51">51</xref>,
     <xref ref-type="bibr" rid="B83">83</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Basic reproductive number</td>
    <td align="left">1.4–6.4</td>
    <td align="left">2–5</td>
    <td align="left">&lt;1</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B51">51</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Median incubation time</td>
    <td align="left">5.2 days</td>
    <td align="left">5 days</td>
    <td align="left">5 days</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B50">50</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Clinical symptoms</td>
    <td align="left">Fever (98%), sough (77%), dyspnea (63.5%), myalgia (11.5%), malaise (35%) and so on</td>
    <td align="left">Fever (&gt;99%), cough (62%–100%),chills or rigor (15%–73%), diarrhea 20%, dyspnea (40%)</td>
    <td align="left">Fever (77%), cough (90%), dyspnea (68%), sputum production (40%), odynophagia (39%), digestive system /signs (20%), hemoptysis (4.3%), myalgia (43%) and headache (20%)</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B53">53</xref>,
     <xref ref-type="bibr" rid="B69">69</xref>,
     <xref ref-type="bibr" rid="B85">85</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Radiology</td>
    <td align="left">Critically ill patients with bilateral multiple lobular and subsegmental areas of consolidation;
     <break/>mild patients with bilateral ground-glass opacity and subsegmental areas of consolidation
     <break/>almost 100% patients with abnormal CT
    </td>
    <td align="left">Unilateral/bilateral ground-glass opacities or focal unilateral/bilateral consolidation. Chest radiography or CT abnormal rate was &gt;94%</td>
    <td align="left">Unilateral/bilateral patchy densities or infiltrates, bilateral hilar infiltration, segmented/lobar opacities, ground-glass opacities and possible small pleural effusions. Chest radiography or CT abnormal rate was between 90% to 100%</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B50">50</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Cytokines</td>
    <td align="left">IL-1β, IL1RA, IL-7, IL-8, IL-9, IL-10, basic FGF, GCSF, GMCSF, IFN-γ, IP10, MCP1, MIP1α, MIP1β, PDGF, TNF-α and VEGF increased, ICU patients also had higher GCSF, TNF-α and T-helper-2 (Th2) cytokines (e.g., IL-4 and IL-10) also increased</td>
    <td align="left">IL-1β, IL-6, IL-12, IFN-γ, IP10 and MCP-1 increased</td>
    <td align="left">Increased concentrations of proinflammatory cytokines (IFN-γ, TNF-α, IL-15 and IL-17)</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B6">6</xref>,
     <xref ref-type="bibr" rid="B50">50</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Treatment medicine</td>
    <td align="left">Corticosteroids, remdesivir, combination of lopinavir and ritonavir, type I interferon and so on</td>
    <td align="left">Lopinavir and ritonavir, corticosteroids, IFN-α, IVIG</td>
    <td align="left">IFN-β, lopinavir and ritonavir, mycophenolic acid</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B67">67</xref>,
     <xref ref-type="bibr" rid="B83">83</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>ACE2: Angiotensin-converting enzyme 2; CT: Computed tomography; DPP4: Dipeptidyl peptidase IV; FGF: Fibroblast growth factor; GCSF: Granulocyte colony stimulating factor; GMCSF: Granulocyte/monocyte colony stimulating factor; ICU: Intensive care unit; IFN-α: Type 1 interferon; IFN-β: Interferon beta; IFN-γ: Interferon gama; IL-1β: Interleukin 1 beta; IL1RA: Interleukin-1 receptor antagonist; IL-6: Interleukin 6; IL-7: Interleukin 7; IL-8: Interleukin 8; IL-9: Interleukin 9; IL-10: Interleukin 10; IL-15: Interleukin 15; IL-17: Interleukin 17; IVIG: Intravenous immunoglobulin; MERS-CoV: Middle East respiratory syndrome coronavirus; TNF-α: tumor necrosis factor-alpha; VEGF: Vascularendothelial growth factor; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
